How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?

scientific article published in October 2005

How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.21349
P698PubMed publication ID16200583
P5875ResearchGate publication ID7563771

P50authorSteven J JacobsenQ37384936
Karla V BallmanQ48925439
Cynthia S CrowsonQ87215892
Hilal Maradit KremersQ88386643
Paulo NicolaQ88783656
W. Michael O'FallonQ102207830
Véronique L. RogerQ110955107
P2093author name stringTerry M Therneau
Sherine E Gabriel
P2860cites workMechanisms and models in heart failure: A combinatorial approachQ33723469
Chronic heart failure in the United States: a manifestation of coronary artery diseaseQ41700419
P433issue10
P921main subjectrheumatoid arthritisQ187255
heart failureQ181754
circulatory systemQ11068
P304page(s)3039-3044
P577publication date2005-10-01
P1433published inArthritis & RheumatologyQ4797636
P1476titleHow much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?
P478volume52

Reverse relations

cites work (P2860)
Q35501450A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis
Q52587395Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity.
Q87035377Arterial stiffness is associated with left ventricular dysfunction in patients with rheumatoid arthritis
Q90623245Associations of inflammatory markers with impaired left ventricular diastolic and systolic function in collagen-induced arthritis
Q85069915Biologics and cardiovascular risk
Q33898103Biologics and heart failure in rheumatoid arthritis: are we any wiser?
Q87997758Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives
Q36355415Cardiac manifestations of rheumatological conditions: a narrative review
Q33582869Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions.
Q89612695Cardiovascular MRI evidence of reduced systolic function and reduced LV mass in rheumatoid arthritis: impact of disease phenotype
Q26823443Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure
Q33806651Cardiovascular morbidity and mortality in rheumatoid arthritis
Q82835412Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model
Q37142052Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs
Q36789902Differing trends in the incidence of vascular comorbidity in MS and the general population
Q34986307Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.
Q40233931Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population
Q35019085Heart disease and rheumatoid arthritis: understanding the risks
Q36742762Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists
Q34090034High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study
Q37141004Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review.
Q34724972Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care
Q34459100Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease
Q37060522Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction
Q38393039Innate immunity and the failing heart: the cytokine hypothesis revisited
Q45265863Left ventricular morphology and function in patients with rheumatoid arthritis
Q44051899Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease
Q52562359Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.
Q49387418Prevalence of left ventricular dysfunction in rheumatoid arthritis
Q28242377Proteomics of citrullination in cardiovascular disease
Q35638288Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis
Q36001551Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative
Q36574986Rheumatoid arthritis and the heart
Q35638369Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis
Q40065441Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
Q41264898Sudden cardiac death in patients with rheumatoid arthritis
Q48214698The Impact of Different Classification Criteria Sets on the Estimated Prevalence and Associated Risk Factors of Diastolic Dysfunction in Rheumatoid Arthritis
Q37027093The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases
Q44558171The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis
Q36596365The heart and cardiovascular manifestations in rheumatoid arthritis
Q35915244The influence of rheumatoid arthritis disease characteristics on heart failure.
Q37074034The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population.
Q36308939To Tell or Not to Tell: Shared Decision Making, CAM Use and Disclosure Among Underserved Patients with Rheumatic Diseases
Q54965764Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis.
Q40555407Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark
Q33697879Why do people with rheumatoid arthritis still die prematurely?

Search more.